Marc Andrew Riedl MD

Professor of Medicine, University of California - San Diego

8899 University Center Lane#230San Diego, CA 92122
Phone+1 858-657-5350

Dr. Riedl is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Riedl's full profile Already have an account?

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Allergy and Immunology, 2001 - 2003
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1998 - 2001
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1998

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2001 - 2027
American Board of Allergy and Immunology Allergy & Immunology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2014, 2016-2017

Clinical Trials

Diesel Exhaust Particles and Leukotriene Production
WITHDRAWN
Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema Start of enrollment: 2013 Dec 02
COMPLETED
PHASE3
A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants Start of enrollment: 2014 May 14
COMPLETED
PHASE1

Publications & Presentations

PubMed

Corticosteroid-Associated Adverse Events in Chronic Spontaneous Urticaria: A US Claims Data Study.
Gil Yosipovitch, Dhaval Patil, Jonathan Rodrigues, Merin Kuruvilla, Tara Raftery
Dermatology and Therapy. 2026-08-01
Correction: Corticosteroid-Associated Adverse Events in Chronic Spontaneous Urticaria: A US Claims Data Study.
Gil Yosipovitch, Dhaval Patil, Jonathan Rodrigues, Merin Kuruvilla, Tara Raftery
Dermatology and Therapy. 2026-08-01
Switching Long-Term Prophylaxis to Donidalorsen for Hereditary Angioedema: 1-Year OASISplus Results.
Marc A Riedl, Jonathan A Bernstein, Joshua S Jacobs, Timothy Craig, William R Lumry
Allergy. 2026-08-01

Journal Articles

Effect of Lanadelumab Compared with Placebo on Prevention of Hereditary Angioedema Attacks
Jonathan A Bernstein, Lawrence B Schwartz, Andrew M Smith, H James Wedner, Daniel Soteres, Timothy Craig, Douglas T Johnston, Aleena Banerji, Paula J Busse, William R ..., JAMA
Population Pharmacokinetics of Subcutaneous C1‐Inhibitor for Prevention of Attacks in Patients with Hereditary Angioedema
Jonathan A Bernstein, Marc A Riedl, Bruce Zuraw, H Henry Li, Timothy Craig, William R Lumry, Clinical and experimental allergy
Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema
Marc Riedl, Jay Kashkin, Clinical Reviews in Allergy & Immunology

Press Mentions

Hereditary Angioedema Pipeline Holding up Long-TermNovember 11th, 2025
DonidalorsenSeptember 3rd, 2025
KalVista Pharmaceuticals Announces FDA Approval of EKTERLY, First and Only Oral on-Demand Treatment for Hereditary AngioedemaJuly 8th, 2025